No record found


* Returns not adjusted for payouts
Company Profile
The Company was incorporated in Pakistan in 1967 as a Public Limited Company under Companies Act, 1913 (now Companies Act, 2017). The Company is a subsidiary of Sanofi Foreign Participations B.V. registered in Netherlands. The ultimate parent of the Company is Sanofi S.A., France. The Company is engaged in the manufacturing, selling and trading of pharmaceutical and related products.
Mr. Asim Jamal | CEO |
Mr. Syed Babar Ali | Chairman |
Mr. Muhammad AbuBakar Siddiq | Company Secretary |
FAMCO Associates (Pvt) Ltd 8-F, Next to Hotel Faran, Nursery, Block -6, P.E.C.H.S Shahrah e Faisal Karachi
EY Ford Rhodes, Chartered Accountants
December
Equity Profile
Announcements
Date | Title | Document |
---|---|---|
May 6, 2022 | Transmission of Quarterly Accounts for the Period Ended March 31, 2022 | View PDF |
Apr 28, 2022 | Financial Results for the Quarter Ended March 31, 2022 | View PDF |
Apr 1, 2022 | Transmission of Annual Report for the Year Ended December 31, 2021 | View PDF |
Mar 25, 2022 | Financial Results for the Year Ended December 31, 2021 | View PDF |
Oct 28, 2021 | Transmission of Financial Statements for Period Ended September 30, 2021 | View PDF |
Oct 27, 2021 | Financial Results for the Period Ended September 30, 2021 | View PDF |
Aug 27, 2021 | SAPL Sanofi-Aventis Pakistan Limited - Half year ended June 30, 2021 Financial Statements | View PDF |
Aug 26, 2021 | Financial Results for the Six Months Ended June 30, 2021 | View PDF |
Apr 30, 2021 | SAPL | Sanofi-Aventis Pakistan Limited - Transmission of Quarterly Report for the period ended March 31, 2021 | |
Apr 30, 2021 | Transmission of Quarterly Accounts for the Period Ended March 31, 2021 | View PDF |
Apr 28, 2021 | Financial Results for the Quarter Ended March 31, 2021 | View PDF |
Mar 30, 2021 | Transmission of Annual Report for the Year Ended December 31, 2020 | View PDF |
Date | Title | Document |
---|---|---|
Apr 25, 2022 | Certified Extract of Resolutions passed at 54th Annual General Meeting | View PDF |
Apr 19, 2022 | Board Meeting for the Quarter ended March 31, 2022 | View PDF |
Apr 4, 2022 | Notice of Annual General Meeting for the Year Ended December 31, 2021 | View PDF |
Mar 17, 2022 | Board Meeting for the Year ended December 31, 2021 | View PDF |
Oct 14, 2021 | Board Meeting for the Period Ended September 30, 2021 | View PDF |
Aug 17, 2021 | Board Meeting | View PDF |
Apr 23, 2021 | Certified Extract of Resolutions passed at 53rd Annual General Meeting | View PDF |
Apr 19, 2021 | Board Meeting for the Quarter ended March 31, 2021 | View PDF |
Mar 30, 2021 | Notice of Annual General Meeting for the Year Ended December 31, 2020 | View PDF |
Feb 18, 2021 | Board Meeting for the Year ended December 31, 2020 | View PDF |
Oct 16, 2020 | Board Meeting for the Period Ended September 30, 2020 | View PDF |
Aug 17, 2020 | BOARD MEETING FOR THE HALF YEAR ENDED JUNE 30, 2020 | View PDF |
Date | Title | Document |
---|---|---|
May 6, 2022 | Credit of Final Cash Dividend for the Year 2021 | View PDF |
May 6, 2022 | Material Information | View PDF |
Apr 28, 2022 | Material Information | View PDF |
Dec 30, 2021 | Material Information | View PDF |
Dec 28, 2021 | Material Information REVOKED | View PDF |
Dec 20, 2021 | Material Information | View PDF |
Nov 22, 2021 | Change of Company Secretary | View |
May 5, 2021 | Credit of Final Cash Dividend for the Year 2020 | View PDF |
Oct 13, 2020 | Corporate Briefing Session for the year 2020 | View PDF |
Aug 17, 2020 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View PDF |
Jun 8, 2020 | Credit of Final Cash Dividend for the Year 2019 | View PDF |
May 20, 2020 | Election of Directors | View PDF |
May 11, 2020 | Notice for Election of Directors u/s 159(4) of the Companies Act, 2017 | View PDF |
Financials
All numbers in thousands (000's) except EPS
2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|
Sales | 15,880,932 | 14,107,802 | 14,500,678 | 12,960,839 |
Profit after Taxation | 905,952 | 493,067 | 154,836 | 612,792 |
EPS | 93.93 | 51.12 | 16.05 | 63.54 |
Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | |
---|---|---|---|---|
Sales | 4,383,649 | 3,849,202 | 4,492,770 | 3,577,847 |
Profit after Taxation | 214,725 | (94,610) | 198,113 | 245,717 |
EPS | 22.26 | (9.81) | 20.54 | 25.48 |

Ratios
2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|
Gross Profit Margin (%) | 25.96 | 26.97 | 25.69 | 30.45 |
Net Profit Margin (%) | 5.70 | 3.49 | 1.07 | 4.73 |
EPS Growth (%) | 83.74 | 218.50 | (74.74) | (39.09) |
PEG | 0.11 | 0.07 | (0.69) | (0.30) |
Payouts
Date | Financial Results | Details | Book Closure |
---|---|---|---|
March 25, 2022 3:38 PM | 31/12/2021(YR) | 300%(F) (D) | 17/04/2022 - 25/04/2022 |
March 2, 2021 2:59 PM | 31/12/2020(YR) | 200%(F) (D) | 13/04/2021 - 23/04/2021 |
March 3, 2020 3:51 PM | 31/12/2019(YR) | 80% (D) | 13/05/2020 - 20/05/2020 |
March 1, 2019 1:38 PM | 31/12/2018(YR) | 300% (F) (D) | 17/04/2019 - 23/04/2019 |
March 7, 2018 3:01 PM | 31/12/2017(YR) | 450% (D) | 20/04/2018 - 26/04/2018 |
March 8, 2017 12:53 PM | 31/12/2016(YR) | 300% (D) | 19/04/2017 - 25/04/2017 |
February 25, 2016 10:14 AM | 31/12/2015(YR) | 30% (D) | 19/04/2016 - 25/04/2016 |
March 12, 2015 1:37 PM | 31/12/2014(YR) | 70% (D) | 21/04/2015 - 27/04/2015 |
February 26, 2014 2:19 PM | 31/12/2013(YR) | 100% (D) | 18/04/2014 - 25/04/2014 |
February 28, 2013 10:15 AM | 31/12/2012(YR) | 125% (F) (D) | 19/04/2013 - 25/04/2013 |